Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntington's Disease - from Clinical Features to the Bench

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|11|10|1218-1236

ISSN： 1389-4501

Source： Current Drug Targets, Vol.11, Iss.10, 2010-10, pp. : 1218-1236

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Strategies for Huntington's Disease: From the Bench to the Clinic

By S. Brocardo Patricia   M. Gil-Mohapel Joana  

Current Psychopharmacology, Vol. 1, Iss. 2, 2012-05 ,pp. : 137-154

Bentham Science Publishers

Access to resources Recommend Favorite

From Preclinical to Clinical Trials: An Update on Potential Therapies for Huntington’s Disease

By S. Brocardo Patricia   M. Gil-Mohapel Joana  

Current Psychopharmacology, Vol. 2, Iss. 2, 2013-05 ,pp. : 113-131

Bentham Science Publishers

Access to resources Recommend Favorite

Tetrabenazine: For Chorea Associated with Huntington's Disease

By Scott Lesley J.  

CNS Drugs, Vol. 25, Iss. 12, 2011-12 ,pp. : 1073-1085

Adis International

Access to resources Recommend Favorite

Renal Protective Effect of Metabolic Therapy in Patients with Coronary Artery Disease and Diabetes: From Bench to Bed Side

By  

Current Pharmaceutical Design, Vol. 15, Iss. 8, 2009-03 ,pp. : 863-882

Bentham Science Publishers

Access to resources Recommend Favorite

Tirapazamine: From Bench to Clinical Trials

By  

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 71-79

Bentham Science Publishers

Access to resources Recommend Favorite